DECIPHERA PHARMACEUTICALS, INC. 10,810,810 Shares of common stock, par value $0.01 per share Underwriting AgreementDeciphera Pharmaceuticals, Inc. • August 15th, 2019 • Pharmaceutical preparations • New York
Company FiledAugust 15th, 2019 Industry JurisdictionDeciphera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 10,810,810 shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,621,621 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.